Wednesday, February 16 2005 18:19 Hrs (IST) - World Time -

Bangalore: Cancer Genetics Inc, a leading biotechnology company in the USA, today (Feb 16, 2005) announced the launch of Genetics Specialties Private Limited, in Bangalore.

Novel genetic diagnostic/prognostic tools for the Indian healthcare market were also launched on the occasion.

Genetics Specialties aims to facilitate genetic reagent technology in India and has formed a strategic alliance with US-based Caner Genetics and Cytotrend (Rockville, Maryland) to distribute cancer diagnostic kits in India, a company statement said.

"Genetics Specialties will offer a complete range of genetic diagnostic probe reagents to the Indian medical and research communities. The primary focus of Genetics Specialties will be to provide an accurate cancer, infectious disease management and the monitoring of birth defects and pre-natal wellness of the people of India," it said.

Genetic Specialties will be launching into the Indian genetics and pathology markets 140 new probes with a menu that is expected to grow at 10 per cent per year over the next two years, according to the statement.

"In the next five years, Genetic Specialties plans to become a publicly traded pre-eminent diagnostic powerhouse offering probes and services in the areas of genetic and infectious diseases in India and surrounding countries," it was stated.